IMPURITIES AVAILABLE FOR 'Icatibant'

Omsynth Lifesciences Pvt. Ltd. is one of the leading manufacturer and exporter of Icatibant. Icatibant is a bradykinin B₂ receptor antagonist used for the treatment of acute attacks of hereditary angioedema (HAE) caused by C1-esterase inhibitor deficiency. It works by competitively blocking the action of bradykinin, a peptide responsible for increased vascular permeability, inflammation, and swelling. By inhibiting bradykinin’s effects, icatibant rapidly reduces symptoms such as skin swelling, abdominal pain, and airway obstruction. It is administered as a subcutaneous injection and provides fast relief, often within hours. The drug is well tolerated, with the most common side effects being injection site reactions, such as redness, swelling, and pain. Icatibant has a short half-life but strong receptor affinity, ensuring quick therapeutic action. It represents a targeted and effective treatment for HAE attacks. Buy high quality Icatibant from Omsynth Lifesciences.